Autophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances
Autophagy is a crucial general survival tactic of mammalian cells. It describes the capability of cells to disassemble and partially recycle cellular components (e.g., mitochondria) in case they are damaged and pose a risk to cell survival or simply if their resources are urgently needed elsewhere a...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7fafd0c438094b7bb78e626e620dd514 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7fafd0c438094b7bb78e626e620dd514 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7fafd0c438094b7bb78e626e620dd5142021-11-11T15:35:45ZAutophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances10.3390/cancers132155752072-6694https://doaj.org/article/7fafd0c438094b7bb78e626e620dd5142021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5575https://doaj.org/toc/2072-6694Autophagy is a crucial general survival tactic of mammalian cells. It describes the capability of cells to disassemble and partially recycle cellular components (e.g., mitochondria) in case they are damaged and pose a risk to cell survival or simply if their resources are urgently needed elsewhere at the time. Autophagy-associated pathomechanisms have been increasingly recognized as important disease mechanisms in non-malignant (neurodegeneration, diffuse parenchymal lung disease) and malignant conditions alike. However, the overall consequences of autophagy for the organism depend particularly on the greater context in which autophagy occurs, such as the cell type or whether the cell is proliferating. In cancer, autophagy sustains cancer cell survival under challenging, i.e., resource-depleted, conditions. However, this leads to situations in which cancer cells are completely dependent on autophagy. Accordingly, autophagy represents a promising yet complex target in cancer treatment with therapeutically induced increase and decrease of autophagic flux as important therapeutic principles.Ingo GanzlebenMarkus F. NeurathChristoph BeckerMDPI AGarticleautophagymitophagyglutaminecancerreverse Warburg effecthydroxychloroquineNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5575, p 5575 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
autophagy mitophagy glutamine cancer reverse Warburg effect hydroxychloroquine Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
autophagy mitophagy glutamine cancer reverse Warburg effect hydroxychloroquine Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Ingo Ganzleben Markus F. Neurath Christoph Becker Autophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances |
description |
Autophagy is a crucial general survival tactic of mammalian cells. It describes the capability of cells to disassemble and partially recycle cellular components (e.g., mitochondria) in case they are damaged and pose a risk to cell survival or simply if their resources are urgently needed elsewhere at the time. Autophagy-associated pathomechanisms have been increasingly recognized as important disease mechanisms in non-malignant (neurodegeneration, diffuse parenchymal lung disease) and malignant conditions alike. However, the overall consequences of autophagy for the organism depend particularly on the greater context in which autophagy occurs, such as the cell type or whether the cell is proliferating. In cancer, autophagy sustains cancer cell survival under challenging, i.e., resource-depleted, conditions. However, this leads to situations in which cancer cells are completely dependent on autophagy. Accordingly, autophagy represents a promising yet complex target in cancer treatment with therapeutically induced increase and decrease of autophagic flux as important therapeutic principles. |
format |
article |
author |
Ingo Ganzleben Markus F. Neurath Christoph Becker |
author_facet |
Ingo Ganzleben Markus F. Neurath Christoph Becker |
author_sort |
Ingo Ganzleben |
title |
Autophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances |
title_short |
Autophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances |
title_full |
Autophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances |
title_fullStr |
Autophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances |
title_full_unstemmed |
Autophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances |
title_sort |
autophagy in cancer therapy—molecular mechanisms and current clinical advances |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/7fafd0c438094b7bb78e626e620dd514 |
work_keys_str_mv |
AT ingoganzleben autophagyincancertherapymolecularmechanismsandcurrentclinicaladvances AT markusfneurath autophagyincancertherapymolecularmechanismsandcurrentclinicaladvances AT christophbecker autophagyincancertherapymolecularmechanismsandcurrentclinicaladvances |
_version_ |
1718435190205841408 |